Why The Equifax (EFX) Story Is Shifting As Analysts Reassess Growth And Risks

2026년 2월 26일 · Unknown · financial · 출처 Yahoo Finance

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.

Equifax’s fair value estimate has been trimmed to US$238.55 from US$243.15, a small reset that still sits just below at least one bank’s reinstated US$250 price target. That spread reflects the split you are seeing in recent research, with some analysts focusing on long term earnings potential and others placing more emphasis on near term risks and the valuation reset. Read on to see what is driving those views and how you can track the story as it evolves.

Stay updated as the Fair Value for Equifax shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Equifax.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

BofA, through analyst Curtis Nagle, reinstated coverage of Equifax with a Buy rating and a US$250 price target, framing the stock within a broader group of Information and Business Services names where the firm is "generally constructive." BofA highlighted expectations for the wider group to post average revenue, EPS and free cash flow growth of 7%, 12% and 11% in 2026. Some investors may see this as support for an earnings and cash flow story at Equifax that could justify a premium valuation if delivered. Morgan Stanley, while cutting its price target, flagged that it sees "enduring EPS growth not priced in." This suggests the firm views the current valuation as not fully reflecting its longer term earnings profile.

🐻 Bearish Takeaways

A broad set of firms, including Goldman Sachs, RBC Capital, Needham, Stifel, JPMorgan, Baird, BMO, UBS, Barclays and Clear Street, have all lowered their Equifax price targets in early February. This points to increased caution around near term execution or valuation. UBS has been weighing AI related concerns and a Senate warning against potential Medicaid related benefits, highlighting that regulatory and technology risks are front of mind for some analysts even as they acknowledge possible offsets.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!NYSE:EFX 1-Year Stock Price Chart

We've flagged 1 risk for Equifax. See which could impact your investment.

How This Changes the Fair Value For Equifax

Fair value trimmed to US$238.55 from US$243.15, based on modestly more conservative assumptions. Long term revenue growth assumption adjusted to 9.95% from 9.59%. Net profit margin assumption set at 15.53% compared with 16.09% previously. Future P/E multiple set at 25.80x, slightly adjusted from 25.85x. Discount rate used in the model set at 7.55%, compared with 7.53% previously.

Story continues

Never Miss an Update: Follow The Narrative

Narratives connect Equifax’s business story to a set of explicit forecasts and a fair value range, updating as new data, products, or risks come through. They help you see how product launches, regulation, and competition might feed into future revenue and earnings.

Head over to the Simply Wall St Community and follow the Narrative on Equifax to stay up to date on:

How new AI enabled tools, cloud platforms, and multi data products like EFX.AI and Single Data Fabric are shaping Equifax’s growth profile and margins. The role of government and eligibility verification demand, The Work Number record base, and international expansion in broadening Equifax’s data moat and revenue mix. Key risks around litigation costs, regulatory scrutiny on data privacy, competitive pressure from alternative credit scores and fintechs, and revenue sensitivity to macro conditions in lending and hiring.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include EFX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

View comments